Chemo Combo Hits a Home Run Against Mantle Cell Lymphoma

According to new data presented at the meeting of the American Association for Cancer Research, a combination of three drugs was responsible for a 100 percent response rate among patients with advanced mantle cell lymphoma.

The trio of drugs included:

  • Vorinostat (Zolinza)
  • Cladribine
  • Rituximab

The study was a small one, with just 37 patients. However, all 37 patients qualified for at least partial response to the therapy, while a stunning 32 patients met the necessary criteria for having had a complete response. The overwhelming majority of these patients had six cycles of the chemotherapy combination.

Said Kamal Sharma, DO of the Penn State Hershey Medical Center:

This is a safe and effective combination in previously untreated mantle cell lymphoma. Myelosuppression is the primary toxicity of this regimen and is reversible. This regimen warrants further study in mantle-cell lymphoma and in other B-cell malignancies.

Mantle cell lymphoma remains a difficult subtype of lymphoma to treat, in large part because researchers and doctors are learning new things about this disease all of the time. Currently, there is no widely accepted standard of care for advanced stage mantle cell lymphoma.

Source: AACR

More Articles

More Articles

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

Small lymphocytic lymphoma (SLL), is a type of non-Hodgkin lymphoma characterized by an excess of white blood cells in the...

Lymphoplasmacytic Lymphoma (LPL) is an indolent (slow growing) cancer that affects plasma cells. A plasma cell...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...

Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to patient. The regimen used depends on the type of...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

The question of what the difference is between leukemia and lymphoma is a commonly asked question. We should start by saying that emerging...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

As one of two primary categories of lymphatic cancer, Hodgkin's lymphoma (HL) attacks the patient's white...

The diagnosis of a low grade B cell lymphoma is both a specific and a non-specific diagnosis that contains the following components:

What...

Hearing about lymphoma recurrence is about the least-welcome news a patient can hear. But what exactly does it mean?

To begin, lymphoma...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...